Sunday, September 20, 2026

HomeBusiness NewsSonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13,...

Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 20…

- Advertisement -

WOODSTOCK, Ga.–()–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed